Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.47 |
| ▸ | SQLE | Q14534 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 2/20 | 0.43 |
| ▸ | FNTB | P49356 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL234869 | 1.00 | KMT2A (0.52) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL12285662 | 1.00 | KMT2A (0.52) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL19183172 | 0.88 | KMT2A (0.41) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL28245336 | 0.84 | KMT2A (0.48) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL5604622 | 0.82 | FNTA (0.58) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL5604687 | 0.82 | FNTA (0.58) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL5604249 | 0.82 | FNTA (0.58) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL5604645 | 0.82 | FNTA (0.58) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL14867331 | 0.82 | KMT2A (0.50) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL14548113 | 0.82 | KMT2A (0.50) | KMT2AALOX15MEN1CYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | claimed |
| CN-118561797-B | Benzopyran antibacterial peptide mimics with broad-spectrum antibacterial activity, and preparation method and application thereof | 聊城大学 | 2025-02-18 | — | — | CN | claimed |
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| CN-119114033-A | Low-protein-adsorptivity blood perfusion adsorbent, preparation method thereof and blood perfusion device | 泉州师范学院 | 2024-12-13 | — | — | CN | claimed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| WO-2024190912-A1 | METHOD FOR SUPPRESSING VITAMIN ODOR | 味の素株式会社 | 2024-09-19 | — | — | WO | claimed |
| CN-118561797-A | Benzopyran antibacterial peptide mimics with broad-spectrum antibacterial activity, and preparation method and application thereof | 聊城大学 | 2024-08-30 | — | — | CN | claimed |
| CN-118252966-A | High-crosslinking amphiphilic embolic microsphere and preparation method thereof | 至微(深圳)医学科技有限公司 | 2024-06-28 | — | — | CN | claimed |
| WO-1999045912-A1 | MONOTERPENOID DERIVATIVES FOR TREATMENT OF CANCER | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-09-16 | — | — | WO | claimed |
| US-5906992-A | POLYACRYLATE, HYDROCARBON PROPELLANT, PENTASODIUM TRIPHOSPHATE, ETHER SOLVENT WITH MITICIDE | COLGATE PALMOLIVE COMPANY (US) | 1999-05-25 | — | — | US | claimed |
| US-5626852-A | HYDROLYSIS OF ACETAL AND/OR KETAL | THE MENNEN COMPANY (US) | 1997-05-06 | — | — | US | claimed |
| EP-0625905-A4 | COMPOSITION CONTAINING BODY ACTIVATED FRAGRANCE FOR CONTACTING THE SKIN AND METHOD OF USE. | MENNEN CO (US) | 1997-02-26 | — | — | EP | claimed |
| EP-0625905-A1 | COMPOSITION CONTAINING BODY ACTIVATED FRAGRANCE FOR CONTACTING THE SKIN AND METHOD OF USE | THE MENNEN COMPANY (US) | 1994-11-30 | — | — | EP | claimed |
| WO-1994006441-A1 | COMPOSITION CONTAINING BODY ACTIVATED FRAGRANCE FOR CONTACTING THE SKIN AND METHOD OF USE | THE MENNEN COMPANY (US) | 1994-03-31 | — | — | WO | claimed |
| US-4832059-A | ADDING CITRAL ACETAL AND AGING | LORILLARD, INC. (US) | 1989-05-23 | — | — | US | claimed |
| US-4728540-A | ABSORPTION FROM SOLUTION CONTAINING PLASTICIZER | ARMOR ALL PRODUCTS CORPORATION | 1988-03-01 | — | — | US | claimed |
| US-4360606-A | Photo-degradable polymer compositions | OWENS-ILLINOIS, INC. (US) | 1982-11-23 | — | — | US | claimed |
| US-4101720-A | Degradable plastic | OWENS-ILLINOIS, INC. (US) | 1978-07-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | KMT2A 2244/4885ALOX15 40/4885MEN1 3398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.